YR P, M B, CK S. GLYCEMIC CONTROL AND BODY WEIGHT EFFECTS OF 25 MG FULL TABLET VERSUS 12.5 MG HALF TABLET EMPAGLIFLOZIN IN THE TREATMENT OF TYPE 2 DIABETES (T2D): A SINGLE CENTRE EXPERIENCE. J ASEAN Fed Endocr Soc [Internet]. 2021Jul.28 [cited 2024May3];36:44. Available from: https://www.asean-endocrinejournal.org/index.php/JAFES/article/view/1483